B

Bodhkrishan

Director Director DIN 09844338
DIN 09844338 First appointment Dec 2022 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Dec 2022
Shareholding value Locked Premium profile

About Bodhkrishan

Data last updated:

Bodhkrishan has 3 years in corporate governance. Formerly with 1 company, such as Medicyto Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 09844338
Primary Designation Director
First Appointment 30 Dec 2022
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Medicyto Pharma Private Limited U24290UP2022PTC176066
Director30 Dec 20222022Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Medicyto Pharma Private Limited
Premium access

Shareholding and investment profile for Bodhkrishan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bodhkrishan

Bodhkrishan has 3 years in corporate governance. Formerly with 1 company, such as Medicyto Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Bodhkrishan is associated with 0 companies as a director.

Bodhkrishan has expertise in General Business.

Bodhkrishan has 3 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available